RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
Back to Home
MFDS (South Korea)
NOTICE
‘의약외품 범위 지정 검토위원회 구성 및 운영에 관한 규정’제정안 행정예고(식품의약품안전처 공고 제2026-507호)
Published: 10/23/2026Detected: 10/23/2026

Summary preview

Establishes an administrative notice for the proposed MFDS regulations governing the composition and operation of a review committee that determines the scope of medicinal products/exempt devices (i.e., “medical…

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
manufacturing
quality
clinical
safety
labeling
#MFDS
#medical goods
#scope determination
#review committee
#regulatory procedure

Official Source Document
Source Verified

Access the original document directly from MFDS.

View Official Document

More from MFDS (South Korea)

  • 「건강기능식품의 기준 및 규격」 일부개정고시(안) 행정예고(공고 제2026-513호. 2026.10.23)10/23/2026
  • 「건강기능식품의 기준 및 규격」 일부개정고시(안) 행정예고(공고 제2026-512호. 2026.10.23)10/23/2026
  • 「의약품 제조 및 품질관리에 관한 규정」 일부개정고시(안) 행정예고(식품의약품안전처 공고 제2026-500호)10/16/2026
  • 「마약류 관리에 관한 법률 시행규칙」 일부개정령(안) 입법예고(식품의약품안전처 공고 제2026-480호)10/8/2026
  • 「식품의약품 등의 연구개발사업 분류체계」 제정고시안 행정예고(식품의약품안전처 공고 제2026-482호)10/6/2026

Get MFDS (South Korea) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service
  • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.